Restricted accessResearch articleFirst published online 2024-6
Clinical Characteristics,Outcomes,and Risk Factors for Mortality in Pregnant/Puerperal Women with COVID-19 Admitted to ICU in Turkey: A Multicenter,Retrospective Study from a Middle-Income Country
Coronaviruses have been the cause of 3 major outbreaks during the last 2 decades. Information on coronavirus diseases in pregnant women is limited, and even less is known about seriously ill pregnant women. Data are also lacking regarding the real burden of coronavirus disease 2019 (COVID-19) infection in pregnant women from low/middle-income countries. The aim of this study was to determine the characteristics and clinical course of COVID-19 in pregnant/puerperal women admitted to ICUs in Turkey.
Methods
This was a national, multicenter, retrospective study. The study population comprised all SARS-CoV-2-infected pregnant/puerperal women admitted to participating ICUs between 1 March 2020 and 1 January 2022. Data regarding demographics, comorbidities, illness severity, therapies, extrapulmonary organ injuries, non-COVID-19 infections, and maternal and fetal/neonatal outcomes were recorded. LASSO logistic regression and multiple logistic regression analyses were used to identify predictive variables in terms of ICU mortality.
Results
A total of 597 patients (341 pregnant women, 255 puerperal women) from 59 ICUs in 44 hospitals were included and of these patients, 87.1% were unvaccinated. The primary reason for ICU admission was acute hypoxemic respiratory failure in 522 (87.4%), acute hypoxemic respiratory failure plus shock in 14 (2.3%), ischemic cerebrovascular accident (CVA) in 5 (0.8%), preeclampsia/eclampsia/HELLP syndrome in 6 (1.0%), and post-caesarean follow-up in 36 (6.0%). Nonsurvivors were sicker than survivors upon ICU admission, with higher APACHE II (p < 0.001) and SOFA scores (p < 0.001). A total of 181 (30.3%) women died and 280 (46.6%) had received invasive mechanical ventilation (IMV). Myocardial injury, the highest SOFA score during ICU stay, LDH levels on admission, the highest levels of AST during ICU stay, average daily dose of corticosteroids, IMV, prophylactic dose anticoagulation (compared with therapeutic dose anticoagulation), PaO2/FiO2 ratio <100, pulmonary embolism, and shock were identified as predictors of mortality. Rates of premature birth (46.4%), cesarean section (53.7%), fetal distress (15.3%), stillbirth (6.5%), and low birth weight (19.4%) were high. Rates of neonatal death (8%) and respiratory distress syndrome (21%) were also high among live-born infants.
Conclusions
Severe/critical COVID-19 infection during the pregnancy/puerperal period was associated with high maternal mortality and fetal/neonatal complication rates in Turkey.
LongBCariusBMChavezS, et al.Clinical update on COVID-19 for the emergency clinician: presentation and evaluation. Am J Emerg Med. 2022;54:46-57.
3.
ZhangLJiangYWeiM, et al.Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei province. Zhonghua Fu Chan Ke Za Zhi. 2020;55(3):166-171.
4.
LiuDLiLWuX, et al.Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol. 2020;215(1):127-132.
5.
AlloteyJStallingsEBonetM, et al.Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. Br Med J. 2020;370:m3320.
6.
ZambranoLDEllingtonSStridP, et al.Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed sars-cov-2 infection by pregnancy status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641-1647.
7.
Martinez-PortillaRJSotiriadisAChatzakisC, et al.Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx). Ultrasound Obstet Gynecol. 2021;57(2):224-231.
8.
McClymontEAlbertAYAltonGD, et al.Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes. JAMA. 2022;327(20):1983-1991.
9.
BartoloméAÁKassabNAAMelguizoSC, et al.Critical care in SARS-CoV-2 infected pregnant women: a prospective multicenter study. Biomedicines. 2022;10(2):475.
10.
LapinskySE. Management of acute respiratory failure in pregnancy. Semin Respir Crit Care Med. 2017;38(2):201-207.
11.
JamiesonDJHoneinMARasmussenSA, et al.H1n1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374(9688):451-458.
12.
HaakeDAZakowskiPCHaakeDLBrysonYJ. Early treatment with Acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis. 1990;12(5):788-798.
13.
WongSFChowKMLeungTN, et al.Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292-297.
14.
MetzTDCliftonRGHughesBL, et al.Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021;137(4):571-580.
15.
WeiSQBilodeau-BertrandMLiuSAugerN. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193(16):E540-E548.
16.
WangXChenXZhangK. Maternal infection with COVID-19 and increased risk of adverse pregnancy outcomes: a meta-analysis. J Matern Fetal Neonatal Med. 2022;35(25):9368-9375.
17.
SeaselyARBlanchardCTAroraN, et al.Maternal and perinatal outcomes associated with the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Obstet Gynecol. 2022;140(2):262-265.
18.
StridPZapataLBTongVT, et al.Coronavirus disease 2019 (COVID-19) severity among women of reproductive age with symptomatic laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by pregnancy status-United States, 1 January 2020–25 December 2021. Clin Infect Dis. 2022;75(Suppl 2):S317-S325.
PéjuEBelicardFSilvaS, et al.Management and outcomes of pregnant women admitted to intensive care unit for severe pneumonia related to SARS-CoV-2 infection: the multicenter and international COVIDPREG study. Intensive Care Med. 2022;48(9):1185-1196.
21.
SitterMPecksURüdigerM, et al.Pregnant and postpartum women requiring intensive care treatment for COVID-19-first data from the CRONOS-registry. J Clin Med. 2022;11(3):701.
22.
VousdenNRamakrishnanRBunchK, et al.Management and implications of severe COVID-19 in pregnancy in the UK: data from the UK obstetric surveillance system national cohort. Acta Obstet Gynecol Scand. 2022;101(4):461-470.
23.
TakemotoMLSMenezesMOAndreucciCB, et al.The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int J Gynaecol Obstet. 2020;151(1):154-156.
24.
DinizDBritoLRondonG. Maternal mortality and the lack of women-centered care in Brazil during COVID-19: preliminary findings of a qualitative study. Lancet Reg Health Am. 2022;10:100239.
25.
AslamJMasroorMMehmoodQUArshadMJabeenSMushtaqMA. Maternal mortality with SARS-COV-2 during its 4th wave in Pakistan: the vaccine paradox and pregnancy. J Coll Physicians Surg Pak. 2022;32(1):119-121.
26.
HeidaryZGargariOKFathiHZaki-DizajiMGhaemiMRashidiBH. Maternal and neonatal complications, outcomes and possibility of vertical transmission in Iranian women with COVID-19. Arch Iran Med. 2021;24(9):713-721.
27.
NachegaJBSam-AguduNAMachekanoRN, et al.Severe acute respiratory syndrome coronavirus 2 infection and pregnancy in sub-Saharan Africa: a 6-country retrospective cohort analysis. Clin Infect Dis. 2022;75(11):1950-1961.
28.
GajbhiyeRKSawantMSKuppusamyP, et al.Differential impact of COVID-19 in pregnant women from high-income countries and low- to middle-income countries: a systematic review and meta-analysis. Int J Gynaecol Obstet. 2021;155(1):48-56.
TaylorMMKobeissiLKimC, et al.Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action. Lancet Glob Health. 2021;9(3):e366-e371.
ÖzenDSKKirazAKYurtÖFKiliçIZDemirağMD. COVID-19 vaccination rates and factors affecting vaccine hesitancy among pregnant women during the pandemic period in Turkey: a single-center experience. Vaccines (Basel). 2022;10(11):1910.
Birol IlterPPrasadSMutluMA, et al.Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during delta and omicron waves. Ultrasound Obstet Gynecol. 2022;60(1):96-102.
RanieriVMRubenfeldGDThompsonBT, et al.Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526-2533.
37.
FällmarDRostamiEKumlienE, et al.The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care. J Neuroradiol. 2022;49(6):421-427.
38.
AbdelGhaffarMMOmranDElgebalyA, et al.Prediction of mortality in hospitalized Egyptian patients with coronavirus disease-2019: a multicenter retrospective study. PLoS One. 2022;17(1):e0262348.
39.
GulerAAYuce InelTKasifogluT, et al.COVID-19 in familial Mediterranean fever: clinical course and complications related to primary disease. Mod Rheumatol. 2023;33(4):786‐791. doi:https://doi.org/10.1093/mr/roac074
40.
MagenEMerzonEGreenIGolan-CohenAVinkerSIsraelA. Selective IgA deficiency and COVID-19. J Allergy Clin Immunol Pract. 2023;11(6):1936-1938.
41.
KirazASezerOAlemdarA, et al.Contribution of genotypes in prothrombin and factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia. J Med Virol. 2023;95(2):e28457.
42.
DorgalalehATabibianSMohammadaminiM, et al.Do congenital bleeding disorders have a protective effect against COVID-19? A prospective study. Int J Lab Hematol. 2021;43(3):e124-e127.
43.
GündoğanKAkbudakİHHancıP, et al.Clinical outcomes and independent risk factors for 90-day mortality in critically ill patients with respiratory failure infected with SARS-CoV-2: a multicenter study in Turkish intensive care units. Balkan Med J. 2021;38(5):296-303.
44.
AbaliHKutbay OzcelikHAkkutuk OngelE, et al.BeyhanNTokgoz AkyilFTural OnurSAltinS.Prognostic predictors for mortality of patients with COVID-19 in an intensive care unit. J Infect Dev Ctries. 2022;16(10):1555-1563.
45.
VillarJAriffSGunierRB, et al.Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the intercovid multinational cohort study. JAMA Pediatr. 2021;175(8):817-826.
46.
Maza-ArnedoFPaternina-CaicedoASosaCG, et al.Maternal mortality linked to COVID-19 in Latin America: results from a multi-country collaborative database of 447 deaths. Lancet Reg Health Am. 2022;12:100269. doi:https://doi.org/10.1016/j.lana.2022.100269
BaykaraNAkalınHArslantaşMK, et al.Sepsis Study Group. Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study. Crit Care. 2018;22(1):93.
49.
HorbyPLimWSEmbersonJR, et al.Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693-704.
AlhazzaniWEvansLAlshamsiF, et al.Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update. Crit Care Med. 2021;49(3):e219-e234.
YaqoobHGreenbergDHwangF, et al.Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit. J Med Virol. 2022;94(1):349-356.
54.
EdalatifardMAkhtariMSalehiM, et al.Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020;56(6):2002808.
55.
MonrealEDe La MazaSSNatera-VillalbaE, et al.High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2021;40(4):761-769.
56.
BouadmaLMekontso-DessapABurdetC, et al.High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: the COVIDICUS randomized clinical trial. JAMA Intern Med. 2022;182(9):906-916.
57.
TomaziniBMMaiaISCavalcantiAB, et al.Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324(13):1307-1316.
58.
HoJCOoiGCMokTY, et al.High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med. 2003;168(12):1449-1456.
59.
KumarGPatelDHererraM, et al.Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients?J Med Virol. 2022;94(1):372-379.
60.
RECOVERY Collaborative Group, HorbyPWEmbersonJRBasnyatB, et al.Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. medRxiv. 2022;.
61.
AkterFArafYHosenMJ. Corticosteroids for COVID-19: worth it or not?Mol Biol Rep. 2022;49(1):567-576.
GuptaAMadhavanMVSehgalK, et al.Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-1032.
64.
NingQWuDWangX, et al.The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther. 2022;7(1):57.
65.
KatsoularisIFonseca-RodríguezOFarringtonP, et al.Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: nationwide self-controlled cases series and matched cohort study. Br Med J. 2022;377:e069590.
66.
GorogDAStoreyRFGurbelPA, et al.Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium. Nat Rev Cardiol. 2022;19(7):475-495.
FialekBPrucMSmerekaJ, et al.Diagnostic value of lactate dehydrogenase in COVID-19: a systematic review and meta-analysis. Cardiol J. 2022;29(5):751-758.
69.
LeiFLiuYMZhouF, et al.Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology. 2020;72(2):389-398.
Gutiérrez GarcíaIPérez CañadasPMartínez UriarteJ, et al.D-dimer during pregnancy: establishing trimester-specific reference intervals. Scand J Clin Lab Invest. 2018;78(6):439-442.
72.
RusuITurlacuMMicheuMM. Acute myocardial injury in patients with COVID-19: possible mechanisms and clinical implications. World J Clin Cases. 2022;10(3):762-776.
73.
Del PreteAConwayFRoccaDGD, et al.COVID-19, acute myocardial injury, and infarction. Card Electrophysiol Clin. 2022;14(1):29-39.
74.
DupuisCBouadmaLDe MontmollinE, et al.Association between early invasive mechanical ventilation and day-60 mortality in acute hypoxemic respiratory failure related to coronavirus disease-2019 pneumonia. Crit Care Explor. 2021;3(1):e0329.
75.
FriedMWCrawfordJMMospanAR, et al.Patient characteristics and outcomes of 11 721 patients with coronavirus disease 2019 (COVID-19) hospitalized across the United States. Clin Infect Dis. 2021;72(10):e558-e565.
76.
GulMHHtunZMDe PerezVJ, et al.Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US national COVID cohort collaborative. Respir Res. 2023;24(1):59.
77.
LitmanEAYinYNelsonSJCapbaratEKerchnerDAhmadziaHK. Adverse perinatal outcomes in a large United States birth cohort during the COVID-19 pandemic. Am J Obstet Gynecol MFM. 2022;4(3):100577.
78.
BandoliGPalmstenKSmithCJFChambersCD. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am. 2017;43(3):489-502.
79.
MariottiVMarconiAMPardiG. Undesired effects of steroids during pregnancy. J Matern Fetal Neonatal Med. 2004;16(Suppl 2):5-7.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
